CLINICA Research Solutions
CLINICA Research Solutions, headquartered in Indonesia, is a leading player in the clinical research industry, specialising in providing comprehensive research services to pharmaceutical and biotechnology companies. Founded in 2010, the company has established a strong presence across Southeast Asia, focusing on delivering high-quality clinical trial management, regulatory affairs, and data management solutions. With a commitment to innovation and excellence, CLINICA Research Solutions offers unique services that streamline the clinical trial process, ensuring compliance and efficiency. The company has achieved notable milestones, including successful collaborations with major pharmaceutical firms and a growing portfolio of completed studies. Renowned for its expertise and dedication, CLINICA Research Solutions continues to solidify its market position as a trusted partner in advancing medical research and improving patient outcomes.
DitchCarbon Score
How does CLINICA Research Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CLINICA Research Solutions's score of 21 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CLINICA Research Solutions's reported carbon emissions
In 2022, CLINICA Research Solutions reported total carbon emissions of approximately 6,616,000,000 kg CO2e. This figure includes emissions from all three scopes: Scope 1 emissions were about 1,425,000,000 kg CO2e, Scope 2 emissions totalled approximately 242,000,000 kg CO2e, and Scope 3 emissions reached around 6,616,000,000 kg CO2e. Notably, the Scope 3 emissions included significant contributions from purchased goods and services (approximately 4,200,000,000 kg CO2e) and the use of sold products (about 1,290,000,000 kg CO2e). Over the years, CLINICA has shown fluctuations in its emissions, with Scope 1 emissions peaking at about 1,706,000,000 kg CO2e in 2020 and gradually decreasing to 1,425,000,000 kg CO2e by 2022. Scope 2 emissions also saw a decline from approximately 322,000,000 kg CO2e in 2020 to 242,000,000 kg CO2e in 2022. However, Scope 3 emissions have consistently remained high, indicating a significant area for potential improvement. Despite these figures, CLINICA Research Solutions has not publicly committed to specific reduction targets or initiatives, as there are no documented reduction targets or climate pledges available. This lack of formal commitments may reflect a broader industry context where many organisations are still developing comprehensive strategies to address their carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 341,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 280,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 339,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CLINICA Research Solutions is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
